Pharmaceutical monitoring and analysis of a case of severe systemic allergic reaction caused by Wujia shenghua capsules during the postpartum period

ZHAO Mingming; YE Yiqing

doi:10.6039/j.issn.1001-0408.2024.19.17

您当前的位置：

首页 >

文章列表页 >

Pharmaceutical monitoring and analysis of a case of severe systemic allergic reaction caused by Wujia shenghua capsules during the postpartum period

更新时间：2024-10-11

- Pharmaceutical monitoring and analysis of a case of severe systemic allergic reaction caused by Wujia shenghua capsules during the postpartum period
- ZHONGGUO YAOFANG Vol. 35, Issue 19, Pages: 2422-2425(2024)
- 作者机构：
  
  1.浙江大学医学院附属妇产科医院吉林医院药剂科，长春　130042
  2.浙江大学医学院附属妇产科医院药剂科，杭州　310006
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.19.17
  CLC： R969.3
- Published：15 October 2024，
  
  Received：28 April 2024，
  
  Revised：12 August 2024，
- 稿件说明：
移动端阅览
赵明明,叶轶青.1例产褥期使用五加生化胶囊致全身性严重过敏反应的药学监护及分析 ^Δ[J].中国药房,2024,35(19):2422-2425.

ZHAO Mingming,YE Yiqing.Pharmaceutical monitoring and analysis of a case of severe systemic allergic reaction caused by Wujia shenghua capsules during the postpartum period[J].ZHONGGUO YAOFANG,2024,35(19):2422-2425.
赵明明,叶轶青.1例产褥期使用五加生化胶囊致全身性严重过敏反应的药学监护及分析 ^Δ[J].中国药房,2024,35(19):2422-2425. DOI： 10.6039/j.issn.1001-0408.2024.19.17.

ZHAO Mingming,YE Yiqing.Pharmaceutical monitoring and analysis of a case of severe systemic allergic reaction caused by Wujia shenghua capsules during the postpartum period[J].ZHONGGUO YAOFANG,2024,35(19):2422-2425. DOI： 10.6039/j.issn.1001-0408.2024.19.17.

摘要

目的

正确识别和应对产褥期使用五加生化胶囊引起的全身性严重过敏反应，为妇产科用药提供参考，促进合理用药。

方法

临床药师通过参与1例产褥期使用五加生化胶囊后出现全身性严重过敏反应患者的药学监护及治疗过程，筛查该患者住院期间所用药物，评估该过敏反应与五加生化胶囊的关系及可能的发生原因。结果与

结论

该患者全身性严重过敏反应与五加生化胶囊的关系被评估为“很可能相关”，提示过敏体质患者产褥期使用五加生化胶囊时应提高警惕，加强药学监护，尽量避免同时联用相同机制或有潜在相互作用的药物。

Abstract

OBJECTIVE

To correctly identify and respond to severe systemic allergic reactions caused by Wujia shenghua capsules during the postpartum period， provide a reference for medication use in obstetrics and gynecology departments， and promote rational drug use.

METHODS

Clinical pharmacists participated in the pharmaceutical monitoring and treatment process for a case of severe systemic allergic reaction after using Wujia shenghua capsules during the postpartum period. They screened the medication used by the patient during hospitalization and evaluated the relationship between the allergic reaction and Wujia shenghua capsules， as well as the possible causes of the reaction.

RESULTS &

CONCLUSIONS

The relationship between severe systemic allergic reactions in the patient and Wujia shenghua capsules is evaluated as “likely related”， suggesting that patients with the allergic constitution should be vigilant when using Wujia shenghua capsules during the postpartum period， and pharmaceutical monitoring should be strengthened to avoid the simultaneous use of drugs with the same mechanism or potential interactions.

关键词

五加生化胶囊全身性严重过敏反应药学监护药品不良反应

Keywords

severe systemic allergic reactionspharmaceutical monitoringadverse drug reactions

references

王巧月. 五加生化胶囊用于药物流产后出血疗效分析[J]. 中国实用医药，2014，9（22）：159-160.

WANG Q Y. Analysis of therapeutic effect of Wujia shenghua capsule on bleeding after drug abortion[J]. China Pract Med，2014，9（22）：159-160.

中华医学会计划生育学分会. 不全流产保守治疗专家共识[J]. 中华生殖与避孕杂志，2019，39（5）：345-348.

Family Planning Branch of Chinese Medical Association.Expert consensus on conservative treatment of incomplete abortion[J]. Chin J Reprod Contracept，2019，39（5）：345-348.

郑疆. 五加生化胶囊促进产后恢复的临床疗效研究[J]. 中医药学报，2016，44（6）：110-112.

ZHENG J. Clinical effect on postpartum recovery by Wujia shenghua capsules[J]. Acta Chin Med Pharmacol，2016，44（6）：110-112.

张凤华，刘涛，王莎莎，等. 五加生化胶囊和妇炎舒胶囊对人流术后子宫复旧不全患者血清MMP-9、IL-10水平的影响[J]. 医学理论与实践，2024，37（5）：806-809.

ZHANG F H，LIU T，WANG S S，et al. The effects of Wujia biochemical capsules and Fuyanshu capsules on serum MMP-9 and IL-10 levels in patients with incomplete uterine involution after abortion [J]. J Med Theory Pract，2024，37 （5）：806-809.

李强，张若冰，杨玉赫，等. 刺五加叶化学成分及药理作用研究进展[J]. 药学研究，2023，42（7）：495-501.

LI Q，ZHANG R B，YANG Y H，et al. Research progress on chemical constituents and pharmacological action of leaves of Acanthopanax senticosus[J]. J Pharm Res，2023，42（7）：495-501.

李佳萌，孙维红. 刺五加注射液严重不良反应分析[J]. 临床合理用药，2023，16（4）：157-160.

LI J M，SUN W H. Analysis of serious adverse reactions of Acanthopanax senticosus injection[J]. Chin J Clin Ration Drug Use，2023，16（4）：157-160.

陈星，任淑青. 刺五加注射液的少见不良反应[J]. 中国实用神经疾病杂志，2008，11（6）：99-100.

CHEN X，REN S Q. Rare adverse reactions of Acanthopanax senticosus injection[J]. Chin J Pract Nerv Dis，2008，11（6）：99-100.

雷有颖，张建怀. 刺五加注射液致过敏性休克2例[J]. 临床合理用药杂志，2015（1）：87-88.

LEI Y Y，ZHANG J H. Two cases of anaphylactic shock induced by Ciwujia injection[J]. Chin J Clin Rat Drug Use，2015 （1）：87-88.

林志健，黄政凯，张晓朦，等. 基于中成药说明书【不良反应】完善的临床药学服务策略[J]. 北京中医药大学学报，2022，45（10）：985-989.

LIN Z J，HUANG Z K，ZHANG X M，et al. Strategies for clinical pharmaceutical care based on the improvement of “adverse drug reactions” in Chinese patent medicine instructions[J]. J Beijing Univ Tradit Chin Med，2022，45（10）：985-989.

汪戎锦. 基于代谢组学的刺五加叶治疗缺血性脑卒中[D].长春：吉林大学，2021．

WANG R J. Metabolomics-based study on mechanism of Eleutherococcus senticosus （Rupr.& Maxim.） Maxim. leaves in the treatment of ischemic stroke[D]. Changchun：Jilin University，2021.

CARDONA V，ANSOTEGUI I J，EBISAWA M，et al. World Allergy Organization anaphylaxis guidance 2020[J]. World Allergy Organ J，2020，13（10）：100472.

VLAVCHESKI F，DEN HARTOGH D J，GIACCA A， et al. Amelioration of high-insulin-induced skeletal muscle cell insulin resistance by resveratrol is linked to activation of AMPK and restoration of GLUT4 translocation[J]. Nutrients，2020，12（4）：914.

SHEN J Y，ZHU X R，WU Z R，et al. Uvangoletin，extracted from Sarcandra glabra，exerts anticancer activity by inducing autophagy and apoptosis and inhibiting invasion and migration on hepatocellular carcinoma cells[J]. Phytomedicine，2022，94：153793.

王连心，杨硕，魏瑞丽，等.口服中成药临床应用药物警戒指南[J/OL].中国中药杂志，1-7[2024-08-26]. https：//doi.org/10.19540/j.cnki.cjcmm.20240517.501https://doi.org/10.19540/j.cnki.cjcmm.20240517.501.

WANG L X，YANG S，WEI R L，et al. Pharmacovigilance guidelines for clinical application of oral Chinese patent medicine[J/OL].China J Chin Mater Med，1-7[2024-08-26]. https：//doi.org/10.19540/j.cnki.cjcmm.20240517.501https://doi.org/10.19540/j.cnki.cjcmm.20240517.501.

徐家珣，徐慧芳. 中药处方点评在促进临床中成药合理使用中的作用[J]. 中医药管理杂志，2024，38（8）：79-81.

XU J X，XU H F. The role of TCM prescription comments in promoting the rational use of clinical traditional Chinese patent medicines and simple preparations[J]. J Tradit Chin Med Managem，2024，38（8）：79-81.

NISHIMURA T，TOOZE S A. Emerging roles of ATG proteins and membrane lipids in autophagosome formation[J]. Cell Discov，2020，6（1）：32.

FERRO F，SERVAIS S，BESSON P，et al. Autophagy and mitophagy in cancer metabolic remodelling[J]. Semin Cell Dev Biol，2020，98：129-138.

唐志芳，梅全喜，杨光义，等. 中药注射剂主要不良反应类型及救治方法探讨[J]. 中国医院用药评价与分析，2019，19（8）：1013-1016，1020.

TANG Z F，MEI Q X，YANG G Y，et al. Discussion on main types of adverse drug reactions and treatment me- thods of traditional Chinese medicine injections[J]. Eval Anal Drug Use Hosp China，2019，19（8）：1013-1016，1020.

国家药品不良反应监测中心. 药品不良反应信息通报：关注中西药复方制剂的用药风险[J]. 中国药物警戒，2016，13（3）：188-189.

National Adverse Drug Reaction Monitoring Center.Adverse drug reactions information bulletin：paying attention to the drug risk of compound preparations of Chinese and western medicine[J]. Chin J Pharmacovigil，2016，13（3）：188-189.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mining and analysis of adverse drug event signals related to mepolizumab

Pharmaceutical analysis for a patient with rebamipide-induced Stevens-Johnson syndrome by clinical pharmacists

Mining and analysis of risperidone adverse event signals based on FAERS database

我院1 557 例药品不良反应报告分析

我院1557例药品不良反应报告分析

Related Author

CHEN Yaoxin

WU Shaoxing

LI Haoxuan

XU Yinji

GONG Wenjun

ZOU Jian

XU Han

BIAN Yuan

Related Institution

The Second Clinical Medical College， Guangzhou University of Chinese Medicine

Dept. of Respiratory and Critical Care Medicine， Guangdong Provincial Hospital of Traditional Chinese Medicine

Dept. of Clinical Pharmacy，Pengzhou Municipal People’s Hospital， Sichuan Pengzhou

Dept. of Clinical Pharmacy，the Affiliated Zigong Hospital of Southwest Medical University

Personalized Drug Therapy Key Laboratory of Sichuan Province， Dept. of Pharmacy of Sichuan Academy of Medical Sciences·Sichuan Provincial People’s Hospital/Affiliated Hospital of University of Electronic Science and Technology

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰